Evaluation of promoter strength for hepatic gene expression in vivo following adenovirus-mediated gene transfer

Gene Therapy

Volumn 3, Issue 9, 1996, Pages 802-810

  Guo, Z S ^a   Wang, L H ^a   Eisensmith, R C ^a   Woo, S L C ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Adenovirus vectors; Gene therapy; In vivo gene expression; Promoter

Indexed keywords

ALPHA 1 ANTITRYPSIN; ELONGATION FACTOR 1ALPHA;

ADENOVIRUS; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DNA TRANSFECTION; ENHANCER REGION; EXPRESSION VECTOR; FEMALE; GENE EXPRESSION; GENE TRANSFER; HEPATOMA CELL; IMMUNE DEFICIENCY; LIVER; LIVER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; SCID MOUSE; TRANSCRIPTION REGULATION; VIRUS RECOMBINANT;

ADENOVIRUSES, HUMAN; ALPHA 1-ANTITRYPSIN; ANIMALS; CARCINOMA, HEPATOCELLULAR; DNA, VIRAL; ENHANCER ELEMENTS (GENETICS); FEMALE; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; LIVER; LIVER NEOPLASMS; MICE; MICE, INBRED C57BL; MICE, SCID; ORGAN SPECIFICITY; PEPTIDE ELONGATION FACTOR 1; PEPTIDE ELONGATION FACTORS; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; TUMOR CELLS, CULTURED;

ADENOVIRIDAE; ANIMALIA; CUCUMBER MOSAIC VIRUS;

EID: 0029834562     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Serfling E, Jasin M, Schaffner W. Enhancers and eukaryotic gene transcription. Trends Genet 1985; 1: 224-230.
2. McKnight S, Tjian R. Transcriptional selectivity of viral genes in mammalian cells. Cell 1986; 46: 795-805.
3. Kim DW et al. Use of the human elongation factor la promoter as a versatile and efficient expression system. Gene 1990; 91: 217-223.
4. Kim DW, Harada T, Saito I, Miyamura T. An efficient expression vector for stable expression in human liver cells. Gene 1993; 134: 307-308.
5. Gorman C et al. The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfection. Proc Natl Acad Sci USA 1982; 79: 6777-6781.
6. Gorman CM, Moffat LF, Howard BH. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol 1982; 2: 1044-1051.
7. Boshart M et al. A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell 1985; 41: 521-530.
8. Pasleau F, Tocci MJ, Leung F, Kopchick JJ. Growth hormone gene expression in eukaryotic cells by the Rous sarcoma virus long terminal repeat or cytomegalovirus immediate-early promoter. Gene 1985; 38: 227-232.
9. Foecking MK, Hofstetter H. Powerful and versatile enhancer-promoter unit for mammalian expression vectors Gene 1986; 45: 101-105.
10. Martin-Gallardo A et al. A comparison of bovine growth-hormone gene expression in mouse L cells directed by the Moloney murine-leukemia virus long terminal repeat, simian virus 40 early promoter or cytomegalovirus immediate-early promoter. Gene 1988; 70: 51-56.
11. Oellig C, Seliger B. Gene transfer into brain tumor cell lines: reporter gene expression using various cellular and viral promoters. J Neurosci Res 1990; 26: 390-396.
12. Ponder KP et al. Evaluation of relative promoter strength in primary hepatocytes using optimized lipofection. Hum Gene Ther 1991; 2: 41-52.
13. Stratford-Perricaudet LD et al. Evaluation of the transfer and expression in mice of an enzyme-encoding gene using a human adenovirus vector. Hum Gene Ther 1990; 1: 241-256.
14. Stratford-Perricaudet LD, Makeh I, Perricaudet M, Briand P. Widespread long-term gene transfer to mouse skeletal muscles and heart. J Clin Invest 1992; 90: 626-630.
15. Rosenfeld MA et al. Adenovirus-mediated transfer of a recombinant α1-antitrypsin gene to the lung epithelium in vivo. Science 1991; 252: 431-434.
16. Jaffe HA et al. Adenovirus-mediated in vivo gene transfer and expression in normal rat liver. Nat Genet 1992; 1: 372-378.
17. Quantin B, Perricaudet LD, Tajbaksh S, Mandel JL. Adenovirus as an expression vector in muscle cells in vivo. Proc Natl Acad Sci USA 1992; 89: 2581-2584.
18. Yang Y et al. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene transfer. Proc Natl Acad Sci USA 1994; 91: 4407-4411.
19. Barr D et al. Strain related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: comparisons between immunocompetent and immunodeficient inbred strains. Gene Therapy 1995; 2: 151-155.
20. Engelhardt JF, Ye X, Doranz B, Wilson JM. Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc Natl Acad Sci USA 1994; 91: 6196-6200.
21. Fang B et al. Gene therapy for hemophilia B: host immunosuppression prolongs the therapeutic effect of adenovirus-mediated factor IX expression. Hum Gene Ther 1995; 6: 1039-1044.
22. Graham FL, Prevec L. Manipulation of adenovirus vectors. In: EJ Murray (ed). Methods in Molecular Biology: Gene Transfer and Expression Protocols. Vol 7. Humana Press: Clifton, NJ, 1991, pp 109-128.
23. Berkner KL. Expression of heterologous sequences in adenoviral vectors. Curr Top Microbiol Immunol 1992; 158: 39-66.
24. Ali M, Lemoine NR, Ring CJA. The use of DNA viruses as vectors for gene therapy. Gene Therapy 1994; 1: 367-384 (review).
25. Li Q et al. Assessment of recombinant adenoviral vectors for hepatic gene therapy. Hum Gene Ther 1993; 4: 403-409.
26. Fang B et al. Gene therapy for phenylketonuria: phenotypic correction in a genetically deficient mouse model by adenovirus-mediated hepatic gene transfer. Gene Therapy 1994; 1: 247-254.
27. Kay MA et al. In vivo hepatic gene therapy: complete albeit transient correction of factor IX deficiency in hemophilia B dogs. Proc Natl Acad Sci USA 1994, 91: 2353-2357.
28. Dai Y et al. Cellular and humoral immune response to adenoviral vectors containing factor IX gene: toleration of factor IX and vector antigens allows for long-term expression. Proc Natl Acad Sci USA 1995; 92: 1401-1405.
29. Smith TA et al. Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice. Nat Genet 1993; 5: 397-402.
30. Huard J et al. The route of administration is a major determinant of the transduction efficiency of rat tissue by adenoviral recombinants. Gene Therapy 1995; 2: 107-115.
31. Hanaoka K, Hayasaka M, Uetsuki T et al. A stable cellular marker for the analysis of mouse chimeras: the bacterial chloramphenicol acetyltransferase gene driven by the human elongation factor 1 alpha promoter. Differentiation 1991; 48: 183-189.
32. Kay MA, Graham F, Leland F, Woo SLC. Therapeutic serum concentrations of human alpha-1-antihypsin after adenoviral-mediated gene transfer into mouse hepatocytes. Hepatology 1995; 21: 815-819.
33. Hanahan D. Transgenic mice as probes into complex systems. Science 1989; 246: 1265-1275 (review).
34. Al-Shawi R, Kinaird J, Burke J, Bishop JO. Expression of a foreign gene in a line of transgenic mice is modulated by a chromosomal position effect. Mol Cell Biol 1990; 10: 1192-1198.
35. Tan SS. Liver-specific and position-effect expression of a retinol-binding protein-lacZ fusion gene (RBP-lacZ) in transgenic mice. Dev Biol 1991; 146: 24-37.
36. Cheng L, Ziegelhoffer PR, Yang N-S. In vivo promoter activity and transgene expression in mammalian somatic tissues evaluated by using particle bombardment. Proc Natl Acad Sci USA 1993; 90: 4455-4459.
37. Rettinger SD et al. Liver-directed gene therapy: quantitative evaluation of promoter elements by using in vivo retroviral transduction. Proc Natl Acad Sci USA 1994; 91: 1460-1464.
38. Kay MA et al. Expression of human α1-antitrypsin in dogs after autologous transplantation of retroviral transduced hepatocytes. Proc Natl Acad Sci USA 1992; 89: 89-93.
39. Emerman M, Temin HM. Genes with promoters in retrovirus vectors can be independently suppressed by an epicogenetic mechanism. Cell 1984; 39: 449-467.
40. Miller DG, Mohammed A, Miller AD. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 1990; 10: 4239-4242.
41. Overbeek PA et al. Tissue-specific expression in transgenic mice of a fused gene containing RSV terminal sequences. Science 1986; 231: 1574-1576.
42. Baskar JF et al. The enhancer domain of the human cytomegalovirus major immediate-early promoter determines cell type-specific expression in transgenic mice. J Virol 1996; 70: 3207-3214.
43. Dai Y, Roman M, Naviaux RK, Verma IM. Gene therapy via primary myoblast: long-term expression of factor IX protein following transplantation in vivo. Proc Natl Acad Sci USA 1992; 89: 10892-10895.
44. Sifers RN, Finegold MJ, Woo SLC. Molecular biology and genetics of alpha1-antitrypsin deficiency. Semin Liver Dis 1992; 12: 301-310.
45. Kay MA et al. Hepatic gene therapy: persistent expression of human alpha1-antitrypsin in mice after direct gene delivery in vivo. Hum Gene Ther 1992; 3: 641-647.
46. Hickman MA et al. Gene expression following direct injection of DNA into liver. Hum Gene Ther 1994; 5: 1477-1483.
47. Takebe Y et al. SRα promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat. Mol Cell Biol 1988; 8: 466-472.
48. Armentano D et al. Effect of internal viral sequences on the utility of retroviral vectors. J Virol 1987; 61: 1647-1650.
49. Liu J et al. Cyclic AMP induction of phosphoenolpyruvate carboxykinase gene transcription is mediated by multiple promoter elements. J Biol Chem 1991; 266: 19095-19102.
50. Qian X, Samadani U, Porcella A, Costa RH. Decreased expression of hepatocyte nuclear factor 3 alpha during the acute-phase response influences transthyretin gene transcription. Mol Cell Biol 1995; 15: 1364-1376
51. Shen R-F et al. Tissue-specific regulation of human α1-antitrypsin gene expression in transgenic mice. DNA 1989; 8: 101-108.
52. Cristiano RJ et al. Hepatic gene therapy: efficient gene delivery and expression in primary hepatocytes utilizing a conjugated adenovirus-DNA complex. Proc Natl Acad Sci USA 1993; 90: 11548-11552.
53. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual, 2nd edn. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY, 1989.
54. Neumann JR, Morency CA, Russian KO. A novel rapid assay for chloramphenicol acetyl transfer gene expression. BioTechniques 1987; 5: 444-446.
55. Guo ZS, Ziff EB. The CCAAT/enhancer binding protein-β family employs a transactivation domain with multiple synergistic components and an active repression domain. J Biol Chem (submitted).